15 results
8-K
EX-99.1
RSLS
ReShape Lifesciences Inc.
14 Nov 22
ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:54pm
Business Innovation Research (SBIR) grant for the development of the company’s proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) device
425
c3ba0bvh z3
18 May 21
Business combination disclosure
9:28am
8-K
EX-99.1
6rjue60s4
25 Oct 19
Obalon Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer
12:00am
8-K
EX-99.1
tvjachc715pndfzd5m7
2 Aug 18
Departure of Directors or Certain Officers
7:55am
- Prev
- 1
- Next